WO2005110052A3 - The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant - Google Patents
The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant Download PDFInfo
- Publication number
- WO2005110052A3 WO2005110052A3 PCT/US2005/016428 US2005016428W WO2005110052A3 WO 2005110052 A3 WO2005110052 A3 WO 2005110052A3 US 2005016428 W US2005016428 W US 2005016428W WO 2005110052 A3 WO2005110052 A3 WO 2005110052A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nitric oxide
- expectorant
- containing gas
- mucolytic agent
- gaseous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
- A61M16/022—Control means therefor
- A61M16/024—Control means therefor including calculation means, e.g. using a processor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0266—Nitrogen (N)
- A61M2202/0275—Nitric oxide [NO]
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005244079A AU2005244079A1 (en) | 2004-05-11 | 2005-05-11 | The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
CA002565230A CA2565230A1 (en) | 2004-05-11 | 2005-05-11 | The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
US11/595,108 US8518457B2 (en) | 2004-05-11 | 2006-11-10 | Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
US14/010,421 US20140141098A1 (en) | 2004-05-11 | 2013-08-26 | Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
US15/884,621 US10987377B2 (en) | 2004-05-11 | 2018-01-31 | Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56988804P | 2004-05-11 | 2004-05-11 | |
US60/569,888 | 2004-05-11 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/595,108 Continuation-In-Part US8518457B2 (en) | 2004-05-11 | 2006-11-10 | Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005110052A2 WO2005110052A2 (en) | 2005-11-24 |
WO2005110052A3 true WO2005110052A3 (en) | 2006-03-02 |
Family
ID=35394611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/016428 WO2005110052A2 (en) | 2004-05-11 | 2005-05-11 | The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2005244079A1 (en) |
CA (1) | CA2565230A1 (en) |
WO (1) | WO2005110052A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7892198B2 (en) | 2000-12-26 | 2011-02-22 | Sensormedics Corporation | Device and method for treatment of surface infections with nitric oxide |
US7955294B2 (en) | 2004-05-11 | 2011-06-07 | Sensormedics Corporation | Intermittent dosing of nitric oxide gas |
US8079998B2 (en) | 2006-10-20 | 2011-12-20 | Pulmonox Technologies Corporation | Methods and devices for the delivery of therapeutic gases including nitric oxide |
US8518457B2 (en) | 2004-05-11 | 2013-08-27 | Pulmonox Technologies Corporation | Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
US8795222B2 (en) | 2000-12-26 | 2014-08-05 | Pulmonox Technologies Corp. | Device and method for treatment of surface infections with nitric oxide |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11324773B2 (en) * | 2017-04-10 | 2022-05-10 | The University Of North Carolina At Chapel Hill | Compounds, compositions and methods for inhibiting a pathogen and/or modifying mucus |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5615669A (en) * | 1994-07-22 | 1997-04-01 | Siemens Elema Ab | Gas mixture and device for delivering the gas mixture to the lungs of a respiratory subject |
US5839433A (en) * | 1993-10-12 | 1998-11-24 | Higenbottam; Timothy William | Nitric oxide treatment |
US6571790B1 (en) * | 1997-05-12 | 2003-06-03 | Robert E. Weinstein | Method and device for organizing and coordinating the combined use of liquid medications for continuous nebulization for the treatment of respiratory disorders |
-
2005
- 2005-05-11 CA CA002565230A patent/CA2565230A1/en not_active Abandoned
- 2005-05-11 WO PCT/US2005/016428 patent/WO2005110052A2/en active Application Filing
- 2005-05-11 AU AU2005244079A patent/AU2005244079A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5839433A (en) * | 1993-10-12 | 1998-11-24 | Higenbottam; Timothy William | Nitric oxide treatment |
US5615669A (en) * | 1994-07-22 | 1997-04-01 | Siemens Elema Ab | Gas mixture and device for delivering the gas mixture to the lungs of a respiratory subject |
US6571790B1 (en) * | 1997-05-12 | 2003-06-03 | Robert E. Weinstein | Method and device for organizing and coordinating the combined use of liquid medications for continuous nebulization for the treatment of respiratory disorders |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7892198B2 (en) | 2000-12-26 | 2011-02-22 | Sensormedics Corporation | Device and method for treatment of surface infections with nitric oxide |
US8795222B2 (en) | 2000-12-26 | 2014-08-05 | Pulmonox Technologies Corp. | Device and method for treatment of surface infections with nitric oxide |
US7955294B2 (en) | 2004-05-11 | 2011-06-07 | Sensormedics Corporation | Intermittent dosing of nitric oxide gas |
US8518457B2 (en) | 2004-05-11 | 2013-08-27 | Pulmonox Technologies Corporation | Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
US8079998B2 (en) | 2006-10-20 | 2011-12-20 | Pulmonox Technologies Corporation | Methods and devices for the delivery of therapeutic gases including nitric oxide |
Also Published As
Publication number | Publication date |
---|---|
CA2565230A1 (en) | 2005-11-24 |
WO2005110052A2 (en) | 2005-11-24 |
AU2005244079A1 (en) | 2005-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3698832B1 (en) | Methods and devices for smoking urge relief | |
CA2963874C (en) | Systems and methods for synthesis of nitric oxide | |
JP2019089775A (en) | Methods of administering high concentrations of nitric oxide | |
WO2008012531A3 (en) | Delivery of gases to the nasal airway | |
RS76704A (en) | Formoterol superfine formulation | |
ATE451920T1 (en) | POWDER INHALING AGENT WITH SUMATRIPTAN AND PRODUCTION METHOD THEREOF | |
JP2012500092A5 (en) | ||
WO2006017069A3 (en) | Method and system of providing therapeutic gas to a patient to prevent breathing airway collapse | |
ATE347361T1 (en) | COMBINATION OF A PDE4 INHIBITOR WITH TIOTROPIUM FOR THE TREATMENT OF OBSTRUCTIVE AIRWAY DISEASES | |
WO2005110052A3 (en) | The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant | |
CA2894531C (en) | Nebulizer mouthpiece for reducing drug loss | |
DK1715859T3 (en) | Method of treating and diagnosing respiratory disorders in sleep by zonisamide and means for carrying out the method | |
WO2004082633A3 (en) | A method of treating a systemic disease | |
Cho et al. | Comparison of the optimal effect-site concentrations of remifentanil for preventing cough during emergence from desflurane or sevoflurane anaesthesia | |
JP2012511948A (en) | Phased respiratory therapy | |
CN204092782U (en) | A kind of medical vaporizer | |
Lindqvist et al. | Minimal flow anaesthesia for short elective day case surgery; high vaporiser settings are needed but still cost-effective | |
Sauret et al. | Intermittent short-term negative pressure ventilation and increased oxygenation in COPD patients with severe hypercapnic respiratory failure | |
RU2009141168A (en) | METHODS AND COMPOSITIONS CONTAINING DESENLAFAXIN OR DULOXETINE FOR THE TREATMENT OF RESPIRATORY DYSFUNCTIONS DURING SLEEP | |
RS20050400A (en) | Pulverulent formulation for inhalation containing tiotropium | |
CN205698819U (en) | A kind of serious symptom internal medicine respirator | |
CN211024605U (en) | Portable conveying device for asthma first aid | |
CN202069966U (en) | Novel high-pressure oxygen inhalation and exhalation pipeline | |
Weksler et al. | Intranasal salbutamol instillation in asthma attack | |
Cangyuan et al. | Clinical Application of Upper Airways Topical Anesthesia in Endotracheal Intubation in Awake Patients of Giant Goiters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2565230 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11595108 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005244079 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2005244079 Country of ref document: AU Date of ref document: 20050511 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005244079 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 11595108 Country of ref document: US |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |